Catalysts for Sandoz Inc
291 tracked
Aug 9, 2024
approval
ENZEEVU (AFLIBERCEPT-ABZV) โ FDA approval
aflibercept biosimilar
โ
Jul 16, 2024
approval
GABAPENTIN โ FDA approval
GABAPENTIN
โ
Jul 16, 2024
approval
GABAPENTIN โ FDA approval
GABAPENTIN
โ
Jul 16, 2024
approval
GABAPENTIN โ FDA approval
GABAPENTIN
โ
Jul 16, 2024
approval
GABAPENTIN โ FDA approval
GABAPENTIN
โ
Jul 16, 2024
approval
GABAPENTIN โ FDA approval
GABAPENTIN
โ
Jun 26, 2024
approval
ONDANSETRON โ FDA approval
Sandoz Inc
โ
Jun 26, 2024
approval
ONDANSETRON โ FDA approval
Sandoz Inc
โ
Jun 24, 2024
approval
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) โ FDA approval
amoxicillin
โ
Jun 12, 2024
approval
HYRIMOZ (ADALIMUMAB-ADAZ) โ FDA approval
HYRIMOZ
โ
May 31, 2024
approval
ONDANSETRON โ FDA approval
ondansetron ODT
โ
May 31, 2024
approval
ONDANSETRON โ FDA approval
ondansetron ODT
โ
May 7, 2024
approval
BUPROPION HYDROCHLORIDE โ FDA approval
BUPROPION HYDROCHLORIDE
โ
Apr 5, 2024
approval
HYRIMOZ (ADALIMUMAB-ADAZ) โ FDA approval
HYRIMOZ
โ
Mar 19, 2024
approval
GLATOPA (GLATIRAMER ACETATE) โ FDA approval
GLATIRAMER ACETATE
โ
Mar 19, 2024
approval
GLATOPA (GLATIRAMER ACETATE) โ FDA approval
GLATIRAMER ACETATE
โ
Mar 5, 2024
approval
JUBBONTI (DENOSUMAB-BBDZ) โ FDA approval
JUBBONTI
โ
Oct 30, 2023
approval
ONDANSETRON โ FDA approval
Sandoz Inc
โ
Oct 23, 2023
approval
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) โ FDA approval
amoxicillin
โ
Oct 13, 2023
approval
AZSTARYS (DEXMETHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
Sandoz Inc
โ
Oct 13, 2023
approval
AZSTARYS (DEXMETHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
Sandoz Inc
โ
Oct 13, 2023
approval
RITALIN LA (METHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
RITALIN LA
โ
Oct 13, 2023
approval
RITALIN LA (METHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
RITALIN LA
โ
Oct 13, 2023
approval
FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
dexmethylphenidate hydrochloride ER
โ
Oct 13, 2023
approval
FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
dexmethylphenidate hydrochloride ER
โ
Sep 8, 2023
approval
HYRIMOZ (ADALIMUMAB-ADAZ) โ FDA approval
HYRIMOZ
โ
Aug 24, 2023
approval
TYRUKO (NATALIZUMAB-SZTN) โ FDA approval
natalizumab biosimilar
โ
Jul 5, 2023
approval
GLATOPA (GLATIRAMER ACETATE) โ FDA approval
GLATIRAMER ACETATE
โ
May 8, 2023
approval
GLATOPA (GLATIRAMER ACETATE) โ FDA approval
GLATIRAMER ACETATE
โ
Apr 21, 2023
approval
PEMETREXED DISODIUM โ FDA approval
Alimta
โ